PlainRecalls
FDA Drug Moderate Class II Terminated

Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-322-01; NDC Unit Dose Card: 60687-322-11

Reported: March 18, 2020 Initiated: November 20, 2019 #D-1003-2020

Product Description

Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-322-01; NDC Unit Dose Card: 60687-322-11

Reason for Recall

CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.

Details

Recalling Firm
American Health Packaging
Units Affected
53,619 cartons
Distribution
Nationwide USA
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-322-01; NDC Unit Dose Card: 60687-322-11. Recalled by American Health Packaging. Units affected: 53,619 cartons.
Why was this product recalled?
CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 18, 2020. Severity: Moderate. Recall number: D-1003-2020.